Lys411
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.6
Powered by Cell Signaling Technology
Home > Mono-methylation Site Page: > Lys411  -  RIOK1 (human)

Site Information
EIASQRtkEERSSQD   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 877067500

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mass spectrometry ( 1 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:
colorectal cancer ( 1 ) , colorectal carcinoma ( 1 )
Relevant cell line - cell type - tissue:

Downstream Regulation
Effects of modification on RIOK1:
protein degradation ( 1 ) , ubiquitination ( 1 )
Effects of modification on biological processes:
cell growth, inhibited ( 1 )

References 

1

Hong X, et al. (2018) Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers. Elife 7
29384474   Curated Info